Protagonist Therapeutics Inc buy Capital One Financial Co.
Start price
30.10.23
/
50%
€73.50
Target price
30.10.24
€30.16
Performance (%)
-
End price
31.10.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 3.378% | 3.378% | 250.917% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Capital_One_Financia for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $32.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von Capital_One_Financia gewählte maximale Laufzeit wurde überschritten